COVID-19 Vaccines
COVID-19 Vaccines: Weekly Roundup (16th June)
By Apollo 24/7, Published on - 16 June 2021, Updated on - 18 October 2022
Share this article
0
0 like
COVID-19 Vaccines
Leave Comment
Recommended for you
COVID-19 Vaccines
Explained: ‘Comorbidities’ for the 45+ age group
Under the second COVID-19 vaccination phase, people over 60 years of age and those aged between 45 to 59 years with certain comorbidities would be eligible for COVID-19 vaccination in the country.
COVID-19 Vaccines
Dosage interval of Covishield vaccine revised to 4 to 8 weeks
The dosage interval of Covishield vaccine has been revised to 4 to 8 weeks after the 1st dose instead of the earlier practised interval of 4-6 weeks.
COVID-19 Vaccines
Breakthrough Infection: Why Getting Vaccinated Is so Important
Contracting a virus after being vaccinated with one or both doses of the vaccine, is referred to as ‘breakthrough infection’.
Subscribe
Sign up for our free Health Library Daily Newsletter
Get doctor-approved health tips, news, and more.
Visual Stories
Do new COVID-19 variants threaten the global vaccination efforts?
Tap to continue exploring
Recommended for you
COVID-19 Vaccines
Explained: ‘Comorbidities’ for the 45+ age group
Under the second COVID-19 vaccination phase, people over 60 years of age and those aged between 45 to 59 years with certain comorbidities would be eligible for COVID-19 vaccination in the country.
COVID-19 Vaccines
Dosage interval of Covishield vaccine revised to 4 to 8 weeks
The dosage interval of Covishield vaccine has been revised to 4 to 8 weeks after the 1st dose instead of the earlier practised interval of 4-6 weeks.
COVID-19 Vaccines
Breakthrough Infection: Why Getting Vaccinated Is so Important
Contracting a virus after being vaccinated with one or both doses of the vaccine, is referred to as ‘breakthrough infection’.